Meta-analysis and meta-regression of hypothalamic-pituitary-adrenal axis activity in functional somatic disorders

Biological Psychology

Volumn 87, Issue 2, 2011, Pages 183-194

  Tak, Lineke M ^a   Cleare, Anthony J ^b   Ormel, Johan ^a   Manoharan, Andiappan ^b   Kok, Iris C ^a   Wessely, Simon ^b   Rosmalen, Judith G M ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Chronic fatigue syndrome; Cortisol; Fibromyalgia; Functional somatic disorders; Hypothalamic pituitary adrenal axis; Irritable bowel syndrome; Meta analysis

Indexed keywords

HYDROCORTISONE;

ADULT; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DRUG USE; ENTERITIS; FEMALE; FIBROMYALGIA; FUNCTIONAL DISEASE; FUNCTIONAL SOMATIC DISORDER; GENDER; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOCORTISOLISM; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; META ANALYSIS (TOPIC); NEUROENDOCRINE DISEASE; PHYSICAL ACTIVITY; PHYSICAL DISEASE; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW;

DEPRESSIVE DISORDER; FATIGUE SYNDROME, CHRONIC; FEMALE; FIBROMYALGIA; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; IRRITABLE BOWEL SYNDROME; MALE; MOTOR ACTIVITY; PITUITARY-ADRENAL SYSTEM; PSYCHOPHYSIOLOGIC DISORDERS; PUBLICATION BIAS; RESEARCH DESIGN; SEX CHARACTERISTICS;

EID: 79955887969     PISSN: 03010511     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsycho.2011.02.002     Document Type: Review

References (144)

1. Aaron L.A., Burke M.M., Buchwald D. Overlapping conditions among patients with chronic fatigue syndrome, fibromyalgia, and temporomandibular disorder. Archives of Internal Medicine 2000, 160:221-227.
2. Adam E.K., Hawkley L.C., Kudielka B.M., Cacioppo J.T. Day-to-day dynamics of experience - cortisol associations in a population-based sample of older adults. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:17058-17063.
3. Aggarwal V.R., McBeth J., Zakrzewska J.M., Lunt M., Macfarlane G.J. The epidemiology of chronic syndromes that are frequently unexplained: do they have common associated factors?. International Journal of Epidemiology 2006, 35:468-476.
4. Altemus M., Dale J.K., Michelson D., Demitrack M.A., Gold P.W., Straus S.E. Abnormalities in response to vasopressin infusion in chronic fatigue syndrome. Psychoneuroendocrinology 2001, 26:175-188.
5. Ambrogio A.G., Pecori G.F., Cavagnini F. Drugs and HPA axis. Pituitary 2008, 11:219-229.
6. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 1994, fourth ed.
7. Antonijevic I.A. Depressive disorders-is it time to endorse different pathophysiologies?. Psychoneuroendocrinology 2006, 31:1-15.
8. Badrick E., Kirschbaum C., Kumari M. The relationship between smoking status and cortisol secretion. Journal of Clinical Endocrinology and Metabolism 2007, 92:819-824.
9. Barsky A.J., Borus J.F. Functional somatic syndromes. Annals of Internal Medicine 1999, 130:910-921.
10. Bohmelt A.H., Nater U.M., Franke S., Hellhammer D.H., Ehlert U. Basal and stimulated hypothalamic-pituitary-adrenal axis activity in patients with functional gastrointestinal disorders and healthy controls. Psychosomatic Medicine 2005, 67:288-294.
11. Bonifazi M., Suman A.L., Cambiaggi C., Felici A., Grasso G., Lodi L., Mencarelli M., Muscettola M., Carli G. Changes in salivary cortisol and corticosteroid receptor-alpha mRNA expression following a 3-week multidisciplinary treatment program in patients with fibromyalgia. Psychoneuroendocrinology 2006, 31:1076-1086.
12. Bradburn M.J., Deeks J.J., Altman D.G. METAN-an alternative meta-analysis command. Stata Technical Bulletin 1998, 44:1-15.
13. Broderick J.E., Arnold D., Kudielka B.M., Kirschbaum C. Salivary cortisol sampling compliance: comparison of patients and healthy volunteers. Psychoneuroendocrinology 2004, 29:636-650.
14. Buckley T.M., Schatzberg A.F. On the interactions of the hypothalamic-pituitary-adrenal (HPA) axis and sleep: normal HPA axis activity and circadian rhythm, exemplary sleep disorders. Journal of Clinical Endocrinology and Metabolism 2005, 90:3106-3114.
15. Burke H.M., Davis M.C., Otte C., Mohr D.C. Depression and cortisol responses to psychological stress: a meta-analysis. Psychoneuroendocrinology 2005, 30:846-856.
16. Burr R.L., Jarrett M.E., Cain K.C., Jun S.E., Heitkemper M.M. Catecholamine and cortisol levels during sleep in women with irritable bowel syndrome. Neurogastroenterology and Motility 2009, 21:1148-1157.
17. Calis M., Gokce C., Ates F., Ulker S., Izgi H.B., Demir H., Kirnap M., Sofuoglu S., Durak A.C., Tutus A., Kelestimur F. Investigation of the hypothalamo-pituitary-adrenal axis (HPA) by 1 microg ACTH test and metyrapone test in patients with primary fibromyalgia syndrome. Journal of Endocrinological Investigation 2004, 27:42-46.
18. Catley D., Kaell A.T., Kirschbaum C., Stone A.A. A naturalistic evaluation of cortisol secretion in persons with fibromyalgia and rheumatoid arthritis. Arthritis Care and Research 2000, 13:51-61.
19. Chang L., Sundaresh S., Elliott J., Anton P.A., Baldi P., Licudine A., Mayer M., Vuong T., Hirano M., Naliboff B.D., Ameen V.Z., Mayer E.A. Dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis in irritable bowel syndrome. Neurogastroenterology and Motility 2009, 21:149-159.
20. Cleare A.J. The neuroendocrinology of chronic fatigue syndrome. Endocrine Reviews 2003, 24:236-252.
21. Cleare A.J. The HPA axis and the genesis of chronic fatigue syndrome. Trends in Endocrinology and Metabolism 2004, 15:55-59.
22. Cleare A.J., Bearn J., Allain T., McGregor A., Wessely S., Murray R.M., O'Keane V. Contrasting neuroendocrine responses in depression and chronic fatigue syndrome. Journal of Affective Disorders 1995, 34:283-289.
23. Cleare A.J., Blair D., Chambers S., Wessely S. Urinary free cortisol in chronic fatigue syndrome. American Journal of Psychiatry 2001, 158:641-643.
24. Cleare A.J., Heap E., Malhi G.S., Wessely S., O'Keane V., Miell J. Low-dose hydrocortisone in chronic fatigue syndrome: a randomised crossover trial. Lancet 1999, 353:455-458.
25. Cleare A.J., Miell J., Heap E., Sookdeo S., Young L., Malhi G.S., O'Keane V. Hypothalamo-pituitary-adrenal axis dysfunction in chronic fatigue syndrome, and the effects of low-dose hydrocortisone therapy. Journal of Clinical Endocrinology and Metabolism 2001, 86:3545-3554.
26. Crofford L.J., Pillemer S.R., Kalogeras K.T., Cash J.M., Michelson D., Kling M.A., Sternberg E.M., Gold P.W., Chrousos G.P., Wilder R.L. Hypothalamic-pituitary-adrenal axis perturbations in patients with fibromyalgia. Arthritis and Rheumatism 1994, 37:1583-1592.
27. Crofford L.J., Young E.A., Engleberg N.C., Korszun A., Brucksch C.B., McClure L.A., Brown M.B., Demitrack M.A. Basal circadian and pulsatile ACTH and cortisol secretion in patients with fibromyalgia and/or chronic fatigue syndrome. Brain, Behavior and Immunity 2004, 18:314-325.
28. Deary V., Chalder T., Sharpe M. The cognitive behavioural model of medically unexplained symptoms: a theoretical and empirical review. Clinical Psychology Review 2007, 27:781-797.
29. Demitrack M.A., Dale J.K., Straus S.E., Laue L., Listwak S.J., Kruesi M.J., Chrousos G.P., Gold P.W. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. Journal of Clinical Endocrinology and Metabolism 1991, 73:1224-1234.
30. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clinical Trials 1986, 7:177-188.
31. Dickerson S.S., Kemeny M.E. Acute stressors and cortisol responses: a theoretical integration and synthesis of laboratory research. Psychological Bulletin 2004, 130:355-391.
32. Dickhaus B., Mayer E.A., Firooz N., Stains J., Conde F., Olivas T.I., Fass R., Chang L., Mayer M., Naliboff B.D. Irritable bowel syndrome patients show enhanced modulation of visceral perception by auditory stress. American Journal of Gastroenterology 2003, 98:135-143.
33. Dinan T.G., Majeed T., Lavelle E., Scott L.V., Berti C., Behan P. Blunted serotonin-mediated activation of the hypothalamic-pituitary-adrenal axis in chronic fatigue syndrome. Psychoneuroendocrinology 1997, 22:261-267.
34. Dinan T.G., Quigley E.M., Ahmed S.M., Scully P., O'Brien S., O'Mahony L., O'Mahony S., Shanahan F., Keeling P.W. Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker?. Gastroenterology 2006, 130:304-311.
35. Drossman D.A. The functional gastrointestinal disorders and the Rome III process. Gastroenterology 2006, 130:1377-1390.
36. Duval S., Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 2000, 56:455-463.
37. Edwards S., Clow A., Evans P., Hucklebridge F. Exploration of the awakening cortisol response in relation to diurnal cortisol secretory activity. Life Sciences 2001, 68:2093-2103.
38. Egger M., Davey S.G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. British Medical Journal 1997, 315:629-634.
39. Ehlert U., Gaab J., Heinrichs M. Psychoneuroendocrinological contributions to the etiology of depression, posttraumatic stress disorder, and stress-related bodily disorders: the role of the hypothalamus-pituitary-adrenal axis. Biological Psychology 2001, 57:141-152.
40. Elsenbruch S., Harnish M.J., Orr W.C. Subjective and objective sleep quality in irritable bowel syndrome. American Journal of Gastroenterology 1999, 94:2447-2452.
41. Elsenbruch S., Holtmann G., Oezcan D., Lysson A., Janssen O., Goebel M.U., Schedlowski M. Are there alterations of neuroendocrine and cellular immune responses to nutrients in women with irritable bowel syndrome?. American Journal of Gastroenterology 2004, 99:703-710.
42. Elsenbruch S., Lucas A., Holtmann G., Haag S., Gerken G., Riemenschneider N., Langhorst J., Kavelaars A., Heijnen C.J., Schedlowski M. Public speaking stress-induced neuroendocrine responses and circulating immune cell redistribution in irritable bowel syndrome. American Journal of Gastroenterology 2006, 101:2300-2307.
43. Elsenbruch S., Thompson J.J., Hamish M.J., Exton M.S., Orr W.C. Behavioral and physiological sleep characteristics in women with irritable bowel syndrome. American Journal of Gastroenterology 2002, 97:2306-2314.
44. Eriksson E.M., Andren K.I., Eriksson H.T., Kurlberg G.K. Irritable bowel syndrome subtypes differ in body awareness, psychological symptoms and biochemical stress markers. World Journal of Gastroenterology 2008, 14:4889-4896.
45. Fabian L.A., McGuire L., Page G.G., Goodin B.R., Edwards R.R., Haythornthwaite J. The association of the cortisol awakening response with experimental pain ratings. Psychoneuroendocrinology 2009, 34:1247-1251.
46. Freedland K.E., Reese R.L., Steinmeyer B.C. Multivariable models in biobehavioral research. Psychosomatic Medicine 2009, 71:205-216.
47. Fries E. Hypocortisolemic disorders. Stress. The Brain-Body Connection 2008, 60-77. Key Issues in Mental Health, Karger, Basel. D.H. Helhammer, J. Helhammer (Eds.).
48. Fries E., Hesse J., Hellhammer J., Hellhammer D.H. A new view on hypocortisolism. Psychoneuroendocrinology 2005, 30:1010-1016.
49. Fukudo S., Nomura T., Hongo M. Impact of corticotropin-releasing hormone on gastrointestinal motility and adrenocorticotropic hormone in normal controls and patients with irritable bowel syndrome. Gut 1998, 42:845-849.
50. Fukuda K., Straus S.E., Hickie I., Sharpe M.C., Dobbins J.G., Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Annals of Internal Medicine 1994, 121:953-959.
51. Gaab J., Huster D., Peisen R., Engert V., Schad T., Schurmeyer T.H., Ehlert U. Low-dose dexamethasone suppression test in chronic fatigue syndrome and health. Psychosomatic Medicine 2002, 64:311-318.
52. Geenen R., Jacobs J.W., Bijlsma J.W. Evaluation and management of endocrine dysfunction in fibromyalgia. Rheumatic Disease Clinics of North America 2002, 28:389-404.
53. Giske L., Vollestad N.K., Mengshoel A.M., Jensen J., Knardahl S., Roe C. Attenuated adrenergic responses to exercise in women with fibromyalgia-a controlled study. European Journal of Pain 2008, 12:351-360.
54. Gold P.W., Licinio J., Wong M.L., Chrousos G.P. Corticotropin releasing hormone in the pathophysiology of melancholic and atypical depression and in the mechanism of action of antidepressant drugs. Annals of the New York Academy of Sciences 1995, 771:716-729.
55. Griep, E.N., 2000. Fibromyalgia syndrome. Neuroendocrine perspectives with clinical implications. Dissertation, University of Leiden.
56. Griep E.N., Boersma J.W., de Kloet E.R. Altered reactivity of the hypothalamic-pituitary-adrenal axis in the primary fibromyalgia syndrome. Journal of Rheumatology 1993, 20:469-474.
57. Griep E.N., Boersma J.W., Lentjes E.G., Prins A.P., van der Korst J.K., de Kloet E.R. Function of the hypothalamic-pituitary-adrenal axis in patients with fibromyalgia and low back pain. Journal of Rheumatology 1998, 25:1374-1381.
58. Gur A., Cevik R., Nas K., Colpan L., Sarac S. Cortisol and hypothalamic-pituitary-gonadal axis hormones in follicular-phase women with fibromyalgia and chronic fatigue syndrome and effect of depressive symptoms on these hormones. Arthritis Research and Therapy 2004, 6:232-238.
59. Gursel Y., Ergin S., Ulus Y., Erdogan M.F., Yalcin P., Evcik D. Hormonal responses to exercise stress test in patients with fibromyalgia syndrome. Clinical Rheumatology 2001, 20:401-405.
60. Hamilos D.L., Nutter D., Gershtenson J., Redmond D.P., Clementi J.D., Schmaling K.B., Make B.J., Jones J.F. Core body temperature is normal in chronic fatigue syndrome. Biological Psychiatry 1998, 43:293-302.
61. Heim C., Ehlert U., Hellhammer D.H. The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders. Psychoneuroendocrinology 2000, 25:1-35.
62. Heim C., Nater U.M., Maloney E., Boneva R., Jones J.F., Reeves W.C. Childhood trauma and risk for chronic fatigue syndrome: association with neuroendocrine dysfunction. Archives of General Psychiatry 2009, 66:72-80.
63. Henningsen P., Zimmermann T., Sattel H. Medically unexplained physical symptoms, anxiety, and depression: a meta-analytic review. Psychosomatic Medicine 2003, 65:528-533.
64. Henningsen P., Zipfel S., Herzog W. Management of functional somatic syndromes. Lancet 2007, 369:946-955.
65. Higgins J.P., Thompson S.G. Controlling the risk of spurious findings from meta-regression. Statistics in Medicine 2004, 23:1663-1682.
66. Hudson M., Cleare A.J. The 1microg short Synacthen test in chronic fatigue syndrome. Clinical Endocrinology (Oxford) 1999, 51:625-630.
67. Inder W.J., Prickett T.C., Mulder R.T. Normal opioid tone and hypothalamic-pituitary-adrenal axis function in chronic fatigue syndrome despite marked functional impairment. Clinical Endocrinology (Oxford) 2005, 62:343-348.
68. Izgi H.B., Gokce C., Calis M., Turan T., Kirnap M., Sofuoglu S., Durak A.C., Tutus A., Kelestimur F. Investigation of the hypothalamopituitary-adrenal axis by low-dose (1 ìg) adrenocorticotrophic hormone test and metyrapone test in patients with chronic fatigue syndrome. Endocrinologist 2005, 15:89-92.
69. Izquierdo-Alvarez S., Bocos-Terraz J.P., Bancalero-Flores J.L., Pavon-Romero L., Serrano-Ostariz E., de Miquel C.A. Is there an association between fibromyalgia and below-normal levels of urinary cortisol?. BMC Research Notes 2008, 1:134.
70. Jerjes W.K., Taylor N.F., Peters T.J., Wessely S., Cleare A.J. Urinary cortisol and cortisol metabolite excretion in chronic fatigue syndrome. Psychosomatic Medicine 2006, 68:578-582.
71. Jerjes W.K., Cleare A.J., Wessely S., Wood P.J., Taylor N.F. Diurnal patterns of salivary cortisol and cortisone output in chronic fatigue syndrome. Journal of Affective Disorders 2005, 87:299-304.
72. Kato K., Sullivan P.F., Evengard B., Pedersen N.L. A population-based twin study of functional somatic syndromes. Psychological Medicine 2009, 39:497-505.
73. Kaufmann I., Schelling G., Eisner C., Richter H.P., Krauseneck T., Vogeser M., Hauer D., Campolongo P., Chouker A., Beyer A., Thiel M. Anandamide and neutrophil function in patients with fibromyalgia. Psychoneuroendocrinology 2008, 33:676-685.
74. Kilkens T.O., Honig A., Fekkes D., Brummer R.J. The effects of an acute serotonergic challenge on brain-gut responses in irritable bowel syndrome patients and controls. Alimentary Pharmacology and Therapeutics 2005, 22:865-874.
75. Kirnap M., Colak R., Eser C., Ozsoy O., Tutus A., Kelestimur F. A comparison between low-dose (1 microg), standard-dose (250 microg) ACTH stimulation tests and insulin tolerance test in the evaluation of hypothalamo-pituitary-adrenal axis in primary fibromyalgia syndrome. Clinical Endocrinology (Oxford) 2001, 55:455-459.
76. Kirschbaum C., Hellhammer D.H. Salivary cortisol in psychoneuroendocrine research: recent developments and applications. Psychoneuroendocrinology 1994, 19:313-333.
77. Klerman E.B., Goldenberg D.L., Brown E.N., Maliszewski A.M., Adler G.K. Circadian rhythms of women with fibromyalgia. Journal of Clinical Endocrinology and Metabolism 2001, 86:1034-1039.
78. Klingmann P.O., Kugler I., Steffke T.S., Bellingrath S., Kudielka B.M., Hellhammer D.H. Sex-specific prenatal programming: a risk for fibromyalgia?. Annals of the New York Academy of Sciences 2008, 1148:446-455.
79. Kumari M., Badrick E., Chandola T., Adam E.K., Stafford M., Marmot M.G., Kirschbaum C., Kivimaki M. Cortisol secretion and fatigue: Associations in a community based cohort. Psychoneuroendocrinology 2009, 2009:1476-1485.
80. Landis J.R., Koch G.G. The measurement of observer agreement for categorical data. Biometrics 1977, 33:159-174.
81. Lariviere W.R., Melzack R. The role of corticotropin-releasing factor in pain and analgesia. Pain 2000, 84:1-12.
82. Light K.C., Bragdon E.E., Grewen K.M., Brownley K.A., Girdler S.S., Maixner W. Adrenergic dysregulation and pain with and without acute beta-blockade in women with fibromyalgia and temporomandibular disorder. Journal of Pain 2009, 10:542-552.
83. Luger A., Deuster P.A., Kyle S.B., Gallucci W.T., Montgomery L.C., Gold P.W., Loriaux D.L., Chrousos G.P. Acute hypothalamic-pituitary-adrenal responses to the stress of treadmill exercise. Physiologic adaptations to physical training. New England Journal of Medicine 1987, 316:1309-1315.
84. Macedo J.A., Hesse J., Turner J.D., Meyer J., Hellhammer D.H., Muller C.P. Glucocorticoid sensitivity in fibromyalgia patients: decreased expression of corticosteroid receptors and glucocorticoid-induced leucine zipper. Psychoneuroendocrinology 2008, 33:799-809.
85. MacHale S.M., Cavanagh J.T., Bennie J., Carroll S., Goodwin G.M., Lawrie S.M. Diurnal variation of adrenocortical activity in chronic fatigue syndrome. Neuropsychobiology 1998, 38:213-217.
86. Maes M., Lin A., Bonaccorso S., van H.F., Van G.A., Delmeire L., Biondi M., Bosmans E., Kenis G., Scharpe S. Increased 24-hour urinary cortisol excretion in patients with post-traumatic stress disorder and patients with major depression, but not in patients with fibromyalgia. Acta Psychiatrica Scandinavica 1998, 98:328-335.
87. Majer M., Jones J.F., Unger E.R., Youngblood L.S., Decker M.J., Gurbaxani B., Heim C., Reeves W.C. Perception versus polysomnographic assessment of sleep in CFS and non-fatigued control subjects: results from a population-based study. BMC Neurology 2007, 7:40.
88. Malt E.A., Olafsson S., Lund A., Ursin H. Factors explaining variance in perceived pain in women with fibromyalgia. BMC Musculoskeletal Disorders 2002, 3:12.
89. Mayer E.A., Naliboff B.D., Chang L., Coutinho S.V. V. Stress and irritable bowel syndrome. American Journal of Physiology-Gastrointestinal and Liver Physiology 2001, 280:G519-G524.
90. McEwen B.S. Physiology and neurobiology of stress and adaptation: central role of the brain. Physiology Review 2007, 87:873-904.
91. McKenzie R., O'Fallon A., Dale J., Demitrack M., Sharma G., Deloria M., Garcia-Borreguero D., Blackwelder W., Straus S.E. Low-dose hydrocortisone for treatment of chronic fatigue syndrome: a randomized controlled trial. Journal of the American Medical Association 1998, 280:1061-1066.
92. McLean S.A., Williams D.A., Harris R.E., Kop W.J., Groner K.H., Ambrose K., Lyden A.K., Gracely R.H., Crofford L.J., Geisser M.E., Sen A., Biswas P., Clauw D.J. Momentary relationship between cortisol secretion and symptoms in patients with fibromyalgia. Arthritis and Rheumatism 2005, 52:3660-3669.
93. Meeus M., Nijs J., Van de W.N., Toeback L., Truijen S. Diffuse noxious inhibitory control is delayed in chronic fatigue syndrome: an experimental study. Pain 2008, 139:439-448.
94. Meewisse M.L., Reitsma J.B., de Vries G.J., Gersons B.P., Olff M. Cortisol and post-traumatic stress disorder in adults: systematic review and meta-analysis. British Journal of Psychiatry 2007, 191:387-392.
95. Michaud K., Matheson K., Kelly O., Anisman H. Impact of stressors in a natural context on release of cortisol in healthy adult humans: a meta-analysis. Stress 2008, 11:177-197.
96. Miller G.E., Chen E., Zhou E.S. If it goes up, must it come down? Chronic stress and the hypothalamic-pituitary-adrenocortical axis in humans. Psychological Bulletin 2007, 133:25-45.
97. Moorkens G., Berwaerts J., Wynants H., Abs R. Characterization of pituitary function with emphasis on GH secretion in the chronic fatigue syndrome. Clinical Endocrinology (Oxford) 2000, 53:99-106.
98. Morriss R., Dowrick C., Salmon P., Peters S., Dunn G., Rogers A., Lewis B., Charles-Jones H., Hogg J., Clifford R., Rigby C., Gask L. Cluster randomised controlled trial of training practices in reattribution for medically unexplained symptoms. British Journal of Psychiatry 2007, 191:536-542.
99. Moss-Morris R., Spence M. To " lump" or to " split" the functional somatic syndromes: can infectious and emotional risk factors differentiate between the onset of chronic fatigue syndrome and irritable bowel syndrome?. Psychosomatic Medicine 2006, 68:463-469.
100. Nater U.M., Maloney E., Boneva R.S., Gurbaxani B.M., Lin J.M., Jones J.F., Reeves W.C., Heim C. Attenuated morning salivary cortisol concentrations in a population-based study of persons with chronic fatigue syndrome and well controls. Journal of Clinical Endocrinology and Metabolism 2008, 93:703-709.
101. Nater U.M., Youngblood L.S., Jones J.F., Unger E.R., Miller A.H., Reeves W.C., Heim C. Alterations in diurnal salivary cortisol rhythm in a population-based sample of cases with chronic fatigue syndrome. Psychosomatic Medicine 2008, 70:298-305.
102. Nicolson N.A. Measurement of cortisol. Handbook of Physiological Research Methods in Health Psychology 2007, 37-74. Sage Publications, Inc. L.J. Luecken, L.C. Gallo (Eds.).
103. Ottenweller J.E., Sisto S.A., McCarty R.C., Natelson B.H. Hormonal responses to exercise in chronic fatigue syndrome. Neuropsychobiology 2001, 43:34-41.
104. Paiva E.S., Deodhar A., Jones K.D., Bennett R. Impaired growth hormone secretion in fibromyalgia patients: evidence for augmented hypothalamic somatostatin tone. Arthritis and Rheumatism 2002, 46:1344-1350.
105. Patacchioli F.R., Angelucci L., Dellerba G., Monnazzi P., Leri O. Actual stress, psychopathology and salivary cortisol levels in the irritable bowel syndrome (IBS). Journal of Endocrinological Investigations 2001, 24:173-177.
106. Posserud I., Agerforz P., Ekman R., Bjornsson E.S., Abrahamsson H., Simren M. Altered visceral perceptual and neuroendocrine response in patients with irritable bowel syndrome during mental stress. Gut 2004, 53:1102-1108.
107. Racciatti D., Guagnano M.T., Vecchiet J., De Remigis P.L., Pizzigallo E., Della V.R., Di S.T., Merlitti D., Sensi S. Chronic fatigue syndrome: circadian rhythm and hypothalamic-pituitary-adrenal (HPA) axis impairment. International Journal of Immunopathology and Pharmacology 2001, 14:11-15.
108. Riedel W., Schlapp U., Leck S., Netter P., Neeck G. Blunted ACTH and cortisol responses to systemic injection of corticotropin-releasing hormone (CRH) in fibromyalgia: role of somatostatin and CRH-binding protein. Annals of the New York Academy of Sciences 2002, 966:483-490.
109. Riedel W., Layka H., Neeck G. Secretory pattern of GH, TSH, thyroid hormones, ACTH, cortisol, FSH, and LH in patients with fibromyalgia syndrome following systemic injection of the relevant hypothalamic-releasing hormones. Zeitschrift fur Rheumatologie 1998, 57(Suppl. 2):81-87.
110. Roberts A.D., Charler M.L., Papadopoulos A., Wessely S., Chalder T., Cleare A.J. Does hypocortisolism predict a poor response to cognitive behavioural therapy in chronic fatigue syndrome?. Psychological Medicine 2009, 39:1-8.
111. Roberts A.D., Papadopoulos A.S., Wessely S., Chalder T., Cleare A.J. Salivary cortisol output before and after cognitive behavioural therapy for chronic fatigue syndrome. Journal of Affective Disorders 2009, 115:280-286.
112. Roberts A.D., Wessely S., Chalder T., Papadopoulos A., Cleare A.J. Salivary cortisol response to awakening in chronic fatigue syndrome. British Journal of Psychiatry 2004, 184:136-141.
113. Roberts-Thomson I.C., Knight R.E., Kennaway D.J., Pannall P.R. Circadian rhythms in patients with abdominal pain syndromes. Australian and New Zealand Journal of Medicine 1988, 18:569-574.
114. Rosmalen J.G. The way forward: a case for longitudinal population-based studies in the field of functional somatic syndromes. Journal of Psychosomatic Research 2010, 68:399-401.
115. Rosenthal R., DiMatteo M.R. Meta-analysis: recent developments in quantitative methods for literature reviews. Annual Reviews of Psychology 2001, 52:59-82.
116. Rowbottom D., Keast D., Pervan Z., Goodman C., Bhagat C., Kakulas B., Morton A. The role of glutamine in the aetiology of the chronic fatigue syndrome: A prospective study. Chronic Fatigue Syndrome 1998, 4:3-22.
117. Scott L.V., Medbak S., Dinan T.G. The low dose ACTH test in chronic fatigue syndrome and in health. Clinical Endocrinology (Oxford) 1998, 48:733-737.
118. Scott L.V., Svec F., Dinan T. A preliminary study of dehydroepiandrosterone response to low-dose ACTH in chronic fatigue syndrome and in healthy subjects. Psychiatry Research 2000, 97:21-28.
119. Scott L.V., Medbak S., Dinan T.G. Desmopressin augments pituitary-adrenal responsivity to corticotropin-releasing hormone in subjects with chronic fatigue syndrome and in healthy volunteers. Biological Psychiatry 1999, 45:1447-1454.
120. Scott L.V., Salahuddin F., Cooney J., Svec F., Dinan T.G. Differences in adrenal steroid profile in chronic fatigue syndrome, in depression and in health. Journal of Affective Disorders 1999, 54:129-137.
121. Shufflebotham J., Wetherell M.A., Hince D., Hood S., Lightman S., Nutt D., Probert C., Potokar J. Women with diarrhoea-predominant irritable bowel syndrome show an increased pressure response to 35% carbon dioxide stress challenge. Stress 2009, 12:30-36.
122. Strickland P., Morriss R., Wearden A., Deakin B. A comparison of salivary cortisol in chronic fatigue syndrome, community depression and healthy controls. Journal of Affective Disorders 1998, 47:191-194.
123. Sullivan P.F., Smith W., Buchwald D. Latent class analysis of symptoms associated with chronic fatigue syndrome and fibromyalgia. Psychological Medicine 2002, 32:881-888.
124. Tak L.M., Riese H., De Bock G.H., Manoharan A., Kok I.C., Rosmalen J.G. As good as it gets? A meta-analysis and systematic review of methodological quality of heart rate variability studies in functional somatic disorders. Biological Psychology 2009, 82:101-110.
125. Tak L.M., Rosmalen J.G.M. Psychoneuroendocrinology of functional somatic disorders. Psychoneuroendocrinology Research Trends 2007, 463-495. Nova Science Publishers, Inc., Hauppage, New York. M.T. Czberska (Ed.).
126. Tak L.M., Rosmalen J.G. Dysfunction of stress responsive systems as a risk factor for functional somatic syndromes. Journal of Psychosomatic Research 2010, 68:461-468.
127. Torpy D.J., Papanicolaou D.A., Lotsikas A.J., Wilder R.L., Chrousos G.P., Pillemer S.R. Responses of the sympathetic nervous system and the hypothalamic-pituitary-adrenal axis to interleukin-6: a pilot study in fibromyalgia. Arthritis and Rheumatism 2000, 43:872-880.
128. Uceyler N., Hauser W., Sommer C. A systematic review on the effectiveness of treatment with antidepressants in fibromyalgia syndrome. Arthritis and Rheumatism 2008, 59:1279-1298.
129. van Denderen J.C., Boersma J.W., Zeinstra P., Hollander A.P., van Neerbos B.R. Physiological effects of exhaustive physical exercise in primary fibromyalgia syndrome (PFS): is PFS a disorder of neuroendocrine reactivity?. Scandinavion Journal of Rheumatology 1992, 21:35-37.
130. van der Werf S.P., Prins J.B., Vercoulen J.H., van der Meer J.W., Bleijenberg G. Identifying physical activity patterns in chronic fatigue syndrome using actigraphic assessment. Journal of Psychosomatic Research 2000, 49:373-379.
131. van Houdenhove B., Egle U., Luyten P. The role of life stress in fibromyalgia. Current Rheumatology Reports 2005, 7:365-370.
132. van Rensburg S.J., Potocnik F.C., Kiss T., Hugo F., van Z.P., Mansvelt E., Carstens M.E., Theodorou P., Hurly P.R., Emsley R.A., Taljaard J.J. Serum concentrations of some metals and steroids in patients with chronic fatigue syndrome with reference to neurological and cognitive abnormalities. Brain Research Bulletin 2001, 55:319-325.
133. Videlock E.J., Adeyemo M., Licudine A., Hirano M., Ohning G., Mayer M., Mayer E.A., Chang L. Childhood trauma is associated with hypothalamic-pituitary-adrenal axis responsiveness in irritable bowel syndrome. Gastroenterology 2009, 137:1954-1962.
134. Visser J., Graffelman W., Blauw B., Haspels I., Lentjes E., de Kloet E.R., Nagelkerken L. LPS-induced IL-10 production in whole blood cultures from chronic fatigue syndrome patients is increased but supersensitive to inhibition by dexamethasone. Journal of Neuroimmunology 2001, 119:343-349.
135. Vreeburg S.A., Hoogendijk W.J., van Pelt P.J., Derijk R.H., Verhagen J.C., van Dyck R., Smit J.H., Zitman F.G., Penninx B.W. Major depressive disorder and hypothalamic-pituitary-adrenal axis activity: results from a large cohort study. Archives of General Psychiatry 2009, 66:617-626.
136. Vreeburg S.A., Kruijtzer B.P., van Pelt J., van Dyck R., Derijk R.H., Hoogendijk W.J., Smit J.H., Zitman F.G., Penninx B.W. Associations between sociodemographic, sampling and health factors and various salivary cortisol indicators in a large sample without psychopathology. Psychoneuroendocrinology 2009, 34:1109-1120.
137. Walter S.A., Ardal-Eriksson E., Thorell L.H., Bodemar G., Hallbook O. Pre-experimental stress in patients with irritable bowel syndrome: high cortisol values already before symptom provocation with rectal distensions. Neurogastroenterology and Motility 2006, 18:1069-1077.
138. Wessely S., Nimnuan C., Sharpe M. Functional somatic syndromes: one or many?. Lancet 1999, 354:936-939.
139. Wingenfeld K., Wagner D., Schmidt I., Meinlschmidt G., Hellhammer D.H., Heim C. The low-dose dexamethasone suppression test in fibromyalgia. Journal of Psychosomatic Research 2007, 62:85-91.
140. Wolfe F., Smythe H.A., Yunus M.B., Bennett R.M., Bombardier C., Goldenberg D.L., Tugwell P., Campbell S.M., Abeles M., Clark P. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis and Rheumatism 1990, 33:160-172.
141. Wood B., Wessely S., Papadopoulos A., Poon L., Checkley S. Salivary cortisol profiles in chronic fatigue syndrome. Neuropsychobiology 1998, 37:1-4.
142. Yatham L.N., Morehouse R.L., Chisholm B.T., Haase D.A., MacDonald D.D., Marrie T.J. Neuroendocrine assessment of serotonin (5-HT) function in chronic fatigue syndrome. Canadian Journal of Psychiatry 1995, 40:93-96.
143. Young A.H., Sharpe M., Clements A., Dowling B., Hawton K.E., Cowen P.J. Basal activity of the hypothalamic-pituitary-adrenal axis in patients with the chronic fatigue syndrome (neurasthenia). Biological Psychiatry 1998, 43:236-237.
144. Zarkovic M., Pavlovic M., Pokrajac-Simeunovic A., Ciric J., Beleslin B., Penezic Z., Ognjanovic S., Savic S., Poluga J., Trbojevic B., Drezgic M. [Disorder of adrenal gland function in chronic fatigue syndrome]. Srpski Arhiv za Celokupno Lekarstvo 2003, 131:370-374.